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Abstract 
OBJECTIVES: Our aim was to evaluate the impact of metabolic syndrome (MetS) on cardiac phenotype in adolescents. 
BACKGROUND: A high prevalence of MetS has been reported in adolescents. 
METHODS: Four hundred forty-six nondiabetic American Indian adolescents (age 14 to 20 years, 238 girls) underwent 
clinical evaluation, laboratory testing, and Doppler echocardiography. Age- and gender-specific partition values were 
used to define obesity and hypertension. Metabolic syndrome was defined according to Adult Treatment Panel III criteria, 
modified for adolescents. Left ventricular (LV) hypertrophy and left atrial (LA) dilation were identified using age- and 
gender-specific partition values. 
RESULTS: One hundred eleven participants met criteria for MetS. They had a similar age and gender distribution as 
non-MetS participants. Analysis of covariance, controlling for relevant confounders, demonstrated that participants with 
MetS had higher LV, LA, and aortic root diameters, higher LV relative wall thickness, and greater LV mass index. 
Accordingly, MetS participants showed higher prevalences of LV hypertrophy (43.2% vs. 11.7%) and LA dilation (63.1% 
vs. 21.9%, both p < 0.001) compared with non-MetS participants. In addition, MetS was associated with a reduction in 
midwall shortening, lower transmitral mitral early to atrial peak velocity ratio, and mildly prolonged mitral early 
deceleration time (all p < 0.05). In multiple regression analysis, independently of demographics, obesity, blood pressure, 
and single metabolic components of MetS, clustered MetS was associated with a 2.6-fold higher likelihood of LV 
hypertrophy and a 2.3-fold higher likelihood of LA dilation (both p < or = 0.02). 
CONCLUSIONS: In a population sample of adolescents, MetS is associated with higher prevalences of LV hypertrophy 
and LA dilation and with reduced LV systolic and diastolic function, independently of individual MetS components. 
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